Alnylam Pharmaceuticals admitted defeat, for now, in a lawsuit in Delaware federal court that accused Moderna's blockbuster ...

Health care stocks underperformed the broader market in 2023, with many companies falling short of their profit targets, and ...

We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...

Shares of Moderna Inc. MRNA slid 1.42% to $60.20 Friday, on what proved to be an all-around great trading session for the ...

Moderna has been rebuked by regulators after offering children cash to test the Covid vaccine ...

Alnylam Pharmaceuticals has conceded that Moderna's products do not infringe on its patents, as a court ruling determined.

We recently published a list of Jim Cramer’s Latest Portfolio: Top 9 Stocks to Buy and Sell. Since Moderna Inc (NASDAQ:MRNA) ...

We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...

Moderna ( NASDAQ: MRNA) shares snapped six straight sessions of losses, as the stock closed 0.46% higher at $63.93 on ...

Hussain brings more than 35 years of commercial leadership and operating experience in healthcare, most recently serving as CEO of Vifor Pharma ...

Moderna has been called out by the Prescription Medicines Code of Practice Authority (PMCPA) after a National Health Service ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized clinical trial evaluating the efficacy, safety, ...